Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer.
about
Understanding Care Linkage and Engagement Across 15 Adolescent Clinics: Provider Perspectives and Implications for Newly HIV-Infected YouthImmunologic Control of Mus musculus Papillomavirus Type 1.HPV prophylactic vaccination in males improves the clearance of semen infection.Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancerUpdating the natural history of human papillomavirus and anogenital cancersIncidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.Factors affecting linkage to care and engagement in care for newly diagnosed HIV-positive adolescents within fifteen adolescent medicine clinics in the United States.Cervical cancer screening in the era of human papillomavirus testing and vaccination.Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study.ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism.Prospective comparison of hybrid capture 2 and SPF₁₀-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China.Factors associated with type-specific persistence of high-risk human papillomavirus infection: A population-based study.Persistence or clearance of human papillomavirus infections in women in Ouro Preto, Brazil.
P2860
Q33719265-50A8C613-14D5-414F-ABBE-544F655AA8E3Q35818624-9FA2A1CB-03D3-46B1-8C72-BC22091AF746Q36252874-EF347224-5FC1-43F1-84D1-AD21C85F139DQ36698833-5AA1F23B-3E08-4A72-B6E2-AC85A55619C4Q36979148-CBA84AFB-8871-400D-B789-C63F38817051Q37236452-61D00CCE-3E22-41E5-A212-8017BDFFA8EEQ37724267-35235E98-3A89-42B4-AEF1-39F17E73AFFAQ38050824-9956CEEB-655A-4E4C-A52F-E9E7C3A1DE3EQ38376969-58423B43-E3F3-44BF-9EA7-5DA842F4F2AFQ40091834-C5B5744A-A90A-4F2E-A0D1-F2C93F3710A3Q40142951-064E9490-AE3F-4926-8C11-391E060A2E86Q40664880-3C5FCC90-2640-4F9D-A34A-8FCB13F312F8Q41834631-393A9736-EA75-4361-BE3E-52FB5822E2CF
P2860
Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Long-term persistence of preva ...... cervical precancer and cancer.
@ast
Long-term persistence of preva ...... cervical precancer and cancer.
@en
Long-term persistence of preva ...... cervical precancer and cancer.
@nl
type
label
Long-term persistence of preva ...... cervical precancer and cancer.
@ast
Long-term persistence of preva ...... cervical precancer and cancer.
@en
Long-term persistence of preva ...... cervical precancer and cancer.
@nl
prefLabel
Long-term persistence of preva ...... cervical precancer and cancer.
@ast
Long-term persistence of preva ...... cervical precancer and cancer.
@en
Long-term persistence of preva ...... cervical precancer and cancer.
@nl
P2093
P2860
P50
P356
P1476
Long-term persistence of preva ...... cervical precancer and cancer.
@en
P2093
Greg Rydzak
Jorge Morales
Philip E Castle
Proyecto Epidemiológico Guanacaste Group
Robert D Burk
Rolando Herrero
P2860
P304
P356
10.1093/INFDIS/JIQ116
P407
P577
2011-03-01T00:00:00Z